Biologics

Pharmaceutical drug product derived from biological sources. Big Market Research reports on biologic in diagnostic and biotech industry aids stakeholders to gain a thorough knowledge of current and future market trends. Additionally, it furnishes an exhaustive analysis of driving and restraining factors of growth of the industry along with detailed segmentation, opportunities, and development trends of the marketplace. Moreover, recent news, regulations, policies, and new findings in the market are cited. Significant market data have been mentioned in the study to help investors and businesses to formulate various strategies to sustain and strengthen their position in the market.

No of Reports 1

DNA Sequencing Market by Product (Consumable, Instrument, and Service) Application (Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Others), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real-time Sequencing, Chain Termination Sequencing, and Nanopore Sequencing), and End User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics): Global Opportunity Analysis and Industry Forecast, 2017 - 2025

The global DNA sequencing market was estimated to be $6,243 million in 2017 and is projected to reach $25,470 million in 2025 growing with a CAGR of 19% from 2018 to 2025. DNA sequencing is a type of technology in which several DNA strands can be sequenced through massive parallelization. The DNA sequencing contains both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. ...

  • Publish Date: May 24, 2017
  • $5370